Key Drivers
- Strong gross margin
- High leverage
- Positive free cash
AIAI Summary
XRAY is no longer a dividend/yield story but a high-leverage, execution-dependent turnaround after management cut the dividend and redirected capital to a $120M restructuring plus debt reduction/buybacks, so the stock only merits upside if the company delivers sequential net-debt declines and durable operating cash-flow conversion. Monitor quarterly OCF after restructuring, net leverage (quarter-over-quarter), and margin recovery—if those metrics don't show clear improvement, buybacks or product wins (e.g., dental MRI) will not re-rate the equity.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong gross margin
- •High leverage
- •Positive free cash
XRAY has strong gross margins and positive free cash flow but is weighed down by recurring operating/net losses and very high leverage that create a material solvency risk.
Price Behavior
Key Price Behavior Insights:
- •Downtrend intact
- •Former support = resistance
- •Near last month low
XRAY is in a clear downtrend from last month's high ($14.68) to the recent low ($10.95), trading below prior short-term support ($11.50–$12.80) which now acts as resistance, with a short-term oversold condition that could prompt a bounce but would confirm more bearish momentum if $10.95 breaks on rising volume.
Price fell from last month's high $14.68 to $10.95, leaving
Sentiment & News
Key News Insights:
- •Restructuring & cuts
- •FDA dental MRI
- •Volatile share reaction
Dentsply Sirona reported mixed Q4 results—sales +6.2% but a $146M loss after impairments—launched a $120M restructuring, cut its dividend to prioritize debt reduction and buybacks, won FDA clearance for a dental MRI, and faced investor scrutiny amid volatile stock moves.
The moves should improve balance-sheet focus and strategic growth potential but near-term earnings volatility and governance scrutiny likely keep pressure on the stock
Similar Companies in Healthcare
Other companies in the same sector with AI ratings